CAS: 612-61-3; 7-Chloroquinoline
该化合物是一种有机化合物,其特点是一种有基质结构的有机化合物,在7点方位上将氯原子替换为替代的氯原子,它看起来像是黄色至褐色的灰色固体,以其芳香特性而著称,有助于其稳定性和反应性.该化合物的分子分子式为C9H6ClN,其双循环结构中含有氮原子,这是五氯乙烯的典型特征.7-Croloquinoline主要用于合成各种药品和农用化学品,因为它的生物活动,包括抗微生物和抗疟疾特性.该化合物还被用作较复杂的分子的建筑块.该化合物在有机溶剂中可中中中溶,但水溶性有限.在处理7氯quinoline时,应当采取安全防范措施,因为它可能构成健康风险,包括潜在的毒性.适当的储存和处置方法对于减轻环境影响和确保实验室环境的安全至关重要.
- 英文名称7-Chloroquinoline
- 中文名称7-氯喹啉
- IUPAC名称7-chloroquinoline
- 其它别名7-氯喹啉7-Chloroquinoline; 7-Chloro-4-Nitroquinoline
- CAS编号612-61-3
- MFCD编号:MFCD00956370
- EINECS号:612-108-0
- 分子式:C9H6ClN分子量:163.6
- 产品CID: 1594364
- 产品分类有机原料→分子砌块→芳杂环类化合物→喹啉类化合物
相似化合物
86-98-6 635-27-8 611-35-8物理性质
MSDS等安全信息
- GHS象形图
- GHS符号GHS07;
注释: Exclamation mark - 危险类别急性毒性 类别4(经口)
皮肤腐蚀/刺激 类别2
严重眼刺激 类别2
特定目标器官毒性 - 单次接触 类别3
严重眼刺激 类别2A - 警示词Warning(警告)
- 危险描述H302 |吞咽有害.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
H335 |可能引起呼吸道刺激. - 防范说明P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
- 危险品标志Xi,Xn
- 危险类别码22
- WGK Germany3
欧盟法规
C&L通报REACH预注册上下游产品
CAS号86-98-6 4,7-二氯喹啉 | CAS号98591-57-2 7-氯-4-碘喹啉 | CAS号201230-82-2 carbon monoxide | CAS号98-80-6 苯硼酸 | CAS号1060737-02-1 3-(2-amino-4-ch... | CAS号1203646-03-0 7-chloro-4-quin... | CAS号630-19-3 三甲基乙醛 | CAS号108-42-9 间氯苯胺 | CAS号56-81-5 甘油 | CAS号6338-98-3 8-氨基-7-氯喹啉 | CAS号67360-38-7 喹啉-7-腈 | CAS号71331-02-7 7-溴-8-硝基喹啉 | CAS号89770-32-1 DIMETHYL-QUINOL... | CAS号90562-35-9 7-氯-1,2,3,4-四氢喹啉合成工艺路线路线简述
📜4-Chlorocinnamaldehyde置于氢氧化钾体系中,用 乙醇 作为反应溶剂,650.0 °C,1.33 Pa 条件下,反应 0.75H,反应生成 7-氯喹啉
参考文献:Hickson,Clare L.; Mcnab,Hamish,Journal Of The Chemical Society. Perkin Transactions I,1984,# 7,P. 1569-1572
标题:Hickson,Clare L.; Mcnab,Hamish,Journal Of The Chemical Society. Perkin Transactions I,1984,# 7,P. 1569-1572
海关参考信息
- 2903919090-氯苯
2933310010-吡啶
2939800000-其他生物碱 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2007060558-A1
优先权日:2004-07-30
标 题 :Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents
发明人：SANCHEZ MURIEL; MEUNIER BERNARD
权利人:CENTRE NAT RECH SCIENT
摘要:The invention concerns an aminoquinoline-antibiotic hybrid compound of general formula (I): Q—(Y 1 ) p —(U) p —(Y 2 ) p -A: wherein Q represents an aminoquinoline, (Y 1 ) p (U) p —(Y 2 ) p″ is an optional spacer and A is an antibiotic residue. The invention enables the antibiotic residue activity to be unexpectedly enhanced.
专利号:US-7786138-B2
优先权日:2005-11-18
标题 :Process for making montelukast and intermediates therefor
发明人：BENOVSKY PETR; THIJS LAMBERTUS; OVEREEM ARJANNE; CASTULIK JAKUB; ZHU JIE; BARTOS PETR; SKOUMAL RADOMIR
权利人:SYNTHON BV
摘要:A compound of the following formula n nwherein R′ is a straight or branched C1-C4 alkyl group is useful in processes associated with the synthesis of montelukast and its salts.
专利号:WO-2008035086-A2
优先权日:2006-09-22
标题:Synthesis of leukotriene compounds
专利号:CN-106928136-B
优先权日:2017-02-23
标题:A kind of method of graphene palladium cobalt sequential catalyst synthesis montestron sodium intermediate
专利号:CN-109485667-B
优先权日:2018-12-24
标 题 :Synthesis method of 2-aryl-tetrahydroquinoline-4-boron ester compound
专利号:CN-101712688-A
优先权日:2004-07-30
标题 :Q is an aminoquinoline and A is a hybrid QA molecule of an antibiotic residue, its synthesis and antibacterial agent application
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:Sharma, U.; Kumar, R.; Gupta, S. S.; Chandra, D., Science of Synthesis Knowledge Updates, (2022) 2, 66.
摘要:Sharma, U.; Kumar, R.; Gupta, S. S.; Chandra, D., Science of Synthesis Knowledge Updates, (2022) 2, 89.
摘要:Sharma, U.; Kumar, R.; Gupta, S. S.; Chandra, D., Science of Synthesis Knowledge Updates, (2022) 2, 73.
📝 需求与反馈
尽可能描述清楚需求与问题信息
